poloxalene has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, MG; Cloherty, GA; Hemken, PM; Israeli, E; Quaco, E | 1 |
1 other study(ies) available for poloxalene and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.
Topics: Animals; Antibodies, Viral; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 Testing; Humans; Immunoassay; Nucleocapsid; Poloxalene; SARS-CoV-2; Surface-Active Agents; Vero Cells; Virus Inactivation | 2021 |